Johnson & Johnson (JNJ) beat estimates for second-quarter profit and revenue on Wednesday, driven by strong sales of its drugs, including cancer treatment Darzalex and blockbuster psoriasis drug Stelara....
/Stryker%20Corp_%20HQ%20sign%20-by%20Sundry%20Photography%20via%20Shutterstock.jpg)
Stryker will unveil its Q2 earnings later this month, and analysts project a single-digit profit growth.
Strong revenue growth and product innovations have Wall Street believing that this growth stock will rally 114% over the next 12 months.
/Stryker%20Corp_%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Stryker has recently underperformed the Dow Jones, but Wall Street analysts anticipate a moderate upside for the stock.
The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down -0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.05%. US stock...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.11%. US stock indexes today are...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.06%. US stock indexes today are...
Alphatec's revenue growth could lead to the company becoming profitable, causing the stock to rally. However, there are risks.
What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -1.61%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.82%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...